EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study

Massimo Iavarone iD, Eleonora Alimenti, Massimo Puoti iD, Hamid Hasson, Bianca Monti, Sherrie Bhoori, Francesco Peracchi, Alessia Siribelli iD, Marco Fava, Mariangela Bruccoleri, Marco Merli, Giulia Morsica und 5 weitere

Liver International · 2025

DOI: 10.1111/liv.70437 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, 2025. Verfasst von Massimo Iavarone und 16 weiteren Autor:innen. Beteiligte Einrichtung: Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, HIV Infections, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Conflicting data on hepatocellular carcinoma (HCC) survival in people with HIV (PWH) may depend on tumour aggressiveness and access to curative treatments. We compared outcomes of two HCC cohorts according to HIV status.

Methods

Patients from four tertiary referral centers in Northern Italy with the first HCC diagnosis (2005–2023) were analysed. Clinical characteristics, treatment access, and overall survival (OS) were described by HIV status, using inverse probability treatment weighting and propensity score (IPTW/PS) methods. Cox regression models assessed mortality predictors and recurrence after initial treatment.

Results

Among 606 patients, 143 were PWH and 463 HIV‐negative. PWH were younger (median age 53 vs. 68 years, p < 0.001), predominantly male (87% vs. 75%, p = 0.004), with a lower proportion of Child‐Pugh A cirrhosis (71% vs. 76%, p = 0.01). Despite similar surveillance rates (91% vs. 88%), PWH more frequently presented with BCLC‐C stage HCC (22% vs. 10%, p < 0.001). First‐line curative treatments were offered to 47% of PWH and 60% of HIV‐negative patients ( p = 0.006), while second‐line treatment rates were similar (42% vs. 44%, p = 0.91). During median follow‐up of 32 (11–78) and 36 (19–84) months for PWH and HIV‐negative subjects ( p = 0.04), five‐year OS was 43.4% versus 44.1% ( p = 0.97), median OS was 48 [interquartile range (IQR) 15–127] versus 46 (IQR 21–109) months ( p = 0.97). Multivariable analysis after IPTW/PS showed similar mortality (HR 1.03, 95% CI 0.52–1.99, p = 0.94) but a higher two‐year recurrence rate in PWH (47.4% vs. 22.8%, p = 0.03).

Conclusion

Despite more advanced tumours and higher recurrence, survival in PWH with HCC was similar. Access to curative treatments with aggressive downstaging strategies may counterbalance initial disadvantages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHIV InfectionsLiver NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedItalyLiver CirrhosisNeoplasm Recurrence, LocalPropensity ScoreProportional Hazards ModelsRetrospective Studies

Stichwörter der Autor:innen

AIDSARTBCLCHCCHIVHIV‐negative overall survivalliver transplantationsurgery

Autor:innen und Institutionen

  • Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.
  • CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • School of Medicine, University of Milano-Bicocca, Milan, Italy.
  • ASST GOM Niguarda, Division of Infectious Diseases, Milan, Italy.
  • Unit of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Division of HPB Surgery, Hepatology and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

ORCID-Profile: Massimo Iavarone, Massimo Puoti, Alessia Siribelli, Annalisa De Silvestri, Pietro Lampertico

Förderung

  • Ministero della Salute

Zitieren

APA

Iavarone, M., Alimenti, E., Puoti, M., Hasson, H., Monti, B., Bhoori, S., Peracchi, F., Siribelli, A., Fava, M., Bruccoleri, M., Merli, M., Morsica, G., De Silvestri, A., Bonfanti, P., Castagna, A., Soria, A., & Lampertico, P. (2025). Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study. Liver International. https://doi.org/10.1111/liv.70437

Vancouver

Iavarone M, Alimenti E, Puoti M, Hasson H, Monti B, Bhoori S, et al. Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study. Liver International. 2025. doi:10.1111/liv.70437

BibTeX
@article{Iavarone2025,
  author = {Iavarone, Massimo and Alimenti, Eleonora and Puoti, Massimo and Hasson, Hamid and Monti, Bianca and Bhoori, Sherrie and Peracchi, Francesco and Siribelli, Alessia and Fava, Marco and Bruccoleri, Mariangela and Merli, Marco and Morsica, Giulia and De Silvestri, Annalisa and Bonfanti, Paolo and Castagna, Antonella and Soria, Alessandro and Lampertico, Pietro},
  title = {Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70437}
}
Kostenlos starten →